Ashland Inc. operates globally, providing a diverse range of additives and specialty ingredients through multiple segments including Life Sciences, Personal Care & Household, Specialty Additives, and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical solutions such as controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders. It also focuses on nutrition solutions that include thickeners, stabilizers, emulsifiers, and various additives. Furthermore, the nutraceutical solutions they offer cater to areas like weight management, joint comfort, digestive health, sports nutrition, and general wellness, alongside custom formulation, toll processing, and particle engineering services. In the Personal Care & Household segment, Ashland provides a comprehensive assortment of nature-based, biodegradable, and performance-enhancing ingredients suitable for toothpaste, mouthwashes, denture cleaning, and overall dental care. This segment also includes nature-derived rheology ingredients and biodegradable surface wetting agents for household products. The Specialty Additives segment focuses on delivering rheology modifiers, foam control agents, surfactants, and pH neutralizers, along with advanced ceramics utilized in catalytic converters and environmental filters. The Intermediates and Solvents segment produces 1,4 butanediol and its derivatives, including n-methylpyrrolidone, serving various consumer and industrial markets such as architectural coatings, energy, and pharmaceuticals. The company recorded an operating income of -$26,000,000.00 reflecting its earnings from core operations, and reported a substantial revenue of $2,113,000,000.00 demonstrating its strong market presence. Moreover, the income before tax amounted to -$24,000,000.00 showcasing its pre-tax profitability, while the net income ratio is $0.08 indicating the company's profitability margin. The net total of other income and expenses is $2,000,000.00 reflecting non-core financial activities. Ashland Inc. is positioned to appeal to investors due to its reasonably priced stock at $49.74 which draws interest from a broad array of market participants. Despite this, the stock has a low average trading volume of $616,532.00 suggesting reduced market activity. With a mid-range market capitalization of $2,309,064,998.00 the company is recognized as a steady performer in its field. It is a key player in the $Chemicals - Specialty industry, significantly impacting the overall market landscape, and belongs to the $Basic Materials sector, where it continues to drive innovation and growth.